InvestorsHub Logo
Followers 13
Posts 1181
Boards Moderated 0
Alias Born 10/22/2016

Re: me33 post# 6498

Wednesday, 09/20/2017 7:32:30 PM

Wednesday, September 20, 2017 7:32:30 PM

Post# of 8025
Me33,
Much safer? AMRN will do $175 million in revenues this year. Consistently growing scripts. The drug is very safe. There is 100% probability that AMRN has a >15%RRR in PE. There pipeline is getting other indications for Vascepa due to their 1st amendment win. Multiple billion dollar revenue co within next few years. VCEL has a great pipeline as well but won't reach revenue potential that AMRN will when Reduce-It shows that reducing inflammation is the key $ maker.


"VCEL is a much safer and with greater potential stock than AMRN. IMO chances of RI being successful is 50/50. If RI fails the stock will crush instantly and never recover. Very risky.
Not to mention that AMRN, a company with a single drug and no pipeline, already trades at $1bil+ market cap. "
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent VCEL News